2026 Blue MedicareRx Value Plus (PDP) formulary (drug list)
Contract S2893, plan 001 · Connecticut · 3,150 drugs on file · formulary ID 00026129. Each drug links to its cost in every CMS PDP Region 02 plan.
23 drugs starting with Q.
| Drug name | Tier | 30-day preferred pharmacy | 90-day mail order | Usage management |
|---|---|---|---|---|
| QINLOCK 50 mg TabletRipretinib | 5Specialty Tier | 25% | N/A |
|
| QUETIAPINE 100 mg Tablet, Film Coated | 3Preferred Brand | 17% | 17% |
|
| QUETIAPINE 200 mg Tablet, Film Coated | 3Preferred Brand | 17% | 17% |
|
| QUETIAPINE 25 mg Tablet, Film Coated | 3Preferred Brand | 17% | 17% |
|
| QUETIAPINE 300 mg Tablet, Film Coated | 3Preferred Brand | 17% | 17% |
|
| QUETIAPINE 400 mg Tablet, Film Coated | 3Preferred Brand | 17% | 17% |
|
| QUETIAPINE 50 mg Tablet, Film Coated | 3Preferred Brand | 17% | 17% |
|
| QUETIAPINE FUMARATE 150 mg Tablet, Extended Release | 4Non-Preferred Drug | 32% | 32% |
|
| QUETIAPINE FUMARATE 150 mg Tablet, Film Coated | 3Preferred Brand | 17% | 17% |
|
| QUETIAPINE FUMARATE 200 mg Tablet, Extended Release | 4Non-Preferred Drug | 32% | 32% |
|
| QUETIAPINE FUMARATE 300 mg Tablet, Extended Release | 4Non-Preferred Drug | 32% | 32% |
|
| QUETIAPINE FUMARATE 400 mg Tablet, Extended Release | 4Non-Preferred Drug | 32% | 32% |
|
| QUETIAPINE FUMARATE 50 mg Tablet, Extended Release | 4Non-Preferred Drug | 32% | 32% |
|
| QUINAPRIL 10 mg Tablet | 2Generic | $3.00 | $6.00 | None |
| QUINAPRIL 20 mg Tablet | 2Generic | $3.00 | $6.00 | None |
| QUINAPRIL 40 mg Tablet | 2Generic | $3.00 | $6.00 | None |
| QUINAPRIL 5 mg Tablet | 2Generic | $3.00 | $6.00 | None |
| QUINIDINE SULFATE 200 mg TabletQuinidine Sulfate Tablet | 4Non-Preferred Drug | 32% | 32% | None |
| QUINIDINE SULFATE 300 mg TabletQuinidine Sulfate Tablet | 4Non-Preferred Drug | 32% | 32% | None |
| QUININE SULFATE 324 mg Capsule | 4Non-Preferred Drug | 32% | 32% |
|
| QULIPTA 10 mg TabletAtogepant | 3Preferred Brand | 17% | 17% |
|
| QULIPTA 30 mg TabletAtogepant | 3Preferred Brand | 17% | 17% |
|
| QULIPTA 60 mg TabletAtogepant | 3Preferred Brand | 17% | 17% |
|
PA = prior authorization, ST = step therapy, QL = quantity limit. Costs are the plan’s initial-coverage cost-sharing from the CMS 2026 formulary files; a drug not listed here is not on this plan’s formulary, though a formulary exception may still be possible.